Details

NameSymbolSector
STRIDES PHARMA SCIENCE LIMITEDSTARPharmaceuticals
Open
864.6
High
864.65
Low
791
Close
796.25
Volume
356502
Exchange
nse
Time
23-Jan-2026

Outlook

Score:

1

Rating:

RISKY

Candlestick Pattern

CandlepatternofStridesPharmaScienceis
Marubozu
EstimatedStoplossofStridesPharmaScienceis
864.65
StridesPharmaSciencehasa
Bearishℹ
pattern.
Formationof
Marubozu
candlepatternindicatesStridesPharmaSciencehaschancesof
Continuationℹ
ofthecurrenttrend.

Trend

StridesPharmaScienceisin
Sideways trendℹ
.
PriceofStridesPharmaScienceis
Downℹ
by

12.14

%.
Target
Buy@

830.48

Sell@

992.24

Current@

796.25

Volume

ThetradevolumesofStridesPharmaSciencehavebecome
Deficientℹ
ThevolumetrendforStridesPharmaScienceis
Bearishℹ
,buttheparticipantsare
Weak Sellersℹ
ThetradevolumeofStridesPharmaScienceis

Down

by

37.38

%

Valuation

ThecurrentmarketpriceofStridesPharmaScienceis
Overvaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth6048crandtotalassetsworth6048cr,thebalancesheetofStridesPharmaScienceis:
Balancedℹ
.
Cashflow
StridesPharmaSciencehas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 48cr

.Itis
Upℹ
by

66.2

%.
48.34% i.e. ₹ 684cr earned in operatingℹ
6.29% i.e. ₹ 89cr spent in investingℹ
45.37% i.e. ₹ 642cr spent in financingℹ
0% in otherℹ
StridesPharmaSciencehas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 142cr

.Itis
Downℹ
by

207.58

%.
45.4% i.e. ₹ 701cr earned in operatingℹ
9.72% i.e. ₹ 150cr spent in investingℹ
44.88% i.e. ₹ 693cr spent in financingℹ
0% in otherℹ
Income
TheincomeofStridesPharmaScienceis

₹ 1247cr

and

Profit

is:

₹ 132cr

StridesPharmaScienceProfitisupby:

25.71

%andIncomeisUpby:

10.55

%
TheincomeofStridesPharmaScienceis

₹ 1128cr

and

Profit

is:

₹ 105cr

StridesPharmaScienceProfitisupby:

28.05

%andIncomeisDownby:

6.16

%
TheincomeofStridesPharmaScienceis

₹ 1202cr

and

Profit

is:

₹ 82cr

StridesPharmaScienceProfitisdownby:

7.87

%andIncomeisUpby:

3.71

%
By using this site you agree to the use of cookies to deliver a better site experience.